The timing of when you choose to start hormone therapy (HT) may be important. Beginning HT sooner rather than later may have benefits.
“One of the biggest factors with regard to the risks and benefits of HT is your age and the amount of time since menopause. If you are younger than age 60 or within 10 years of menopause, the data show that the risks are significantly less than originally thought”.
Yes, “younger than age 60 or within 10 years of menopause”, matters.
One of the points of consensus about menopausal hormone therapy (MHT) in the Revised Global Consensus Statement on Menopausal Hormone Therapy: Section A: Benefit/Risk Profile of MHT – endorsed by seven menopause-related organizations – published online 20 June 2016, is:
- “MHT, including tibolone and the combination of conjugated equine estrogens and bazedoxifene (CE/BZA), is the most effective treatment for vasomotor symptoms (VMS) associated with menopause at any age, but benefits are more likely to outweigh risks if initiated for symptomatic women before the age of 60 years or within 10 years after menopause”.
What are VMS?
The International Menopause Society’s definition is:
In Health Topics A-Z you may find:
Your Country may have Links similar to:Meno Martha